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Nifedipine-Associated Acute Psychosis 
JOEL K. KAHN, M.D. 
Ann Arbor, Michigan 
A 84-year-old man was given nifedipine for control of angina pectoris. 
Acute psychosis with paranoid ideation developed soon after he began 
receiving the medication. All symptoms resolved with discontinuation 
of nifedipine. This is the second reported case of nifedipine-associated 
acute psychosis. Alternations in calcium-mediated neurotransmitter 
release, particularly dopamine, may be responsible. Clinicians should 
consider nifedipine when presented with a patient with acute psycho- 
sis. 
The calcium channel antagonists are being used in a variety of vascular 
disorders. These agents have been used with remarkably few serious 
adverse effects [ 11, despite the fact that calcium regulation is vital in 
many biologic processes. Perturbations in calcium homeostasis have 
been described in several psychiatric disorders including mania, depres- 
sion [2], and psychosis [3]; however, the calcium channel antagonists 
have rarely been associated with such disturbances [4,5]. This report 
describes a case of acute psychosis associated with nifedipine use, the 
second such case reported in the literature. 
CASE REPORT 
From the Department of internal Medicine, Uni- 
versity of Michigan Medical School, Ann Arbor, 
Michigan. Reprints are not available. Manuscript 
submitted March 12, 1985 and accepted May 8, 
1985. 
A 84-year-old man was admitted to the cardiology inpatient service for 
control of angina pectoris present for five months. In the weeks prior to 
admission, he had required increasing amounts of topical and sublingual 
nitroglycerin for pain relief. He had a poorly documented history of myocar- 
dial infarction a decade ago but was free of other medical or psychiatric 
problems. He denied symptoms of congestive heart failure or syncope. His 
medications included transdermal nitroglycerin (20 cm2) daily and sublin- 
gual nitroglycerin. Physical examination revealed an alert and pleasant man 
with a blood pressure of 118/82 mm Hg, a pulse of 50 per minute, and a 
respiratory rate of 18 per minute. He was afebrile. His lungs were clear. He 
had a grade 218 murmur characteristic of aortic stenosis but carotid 
upstrokes were normal. The results of neurologic examination and mental 
status were normal except for a moderate bilateral sensorineural hearing 
loss. Laboratory studies revealed normal electrolyte, urea nitrogen, creati- 
nine, calcium, phosphorus, and transaminase values. Thyroid function 
results were normal. Urinalysis and chest roentgenography revealed no 
abnormalities. Electrocardiography shown sinus bradycardia with a rate of 
50 per minute, first-degree atrioventricular block, left anterior fascicular 
block, and an old anteroseptal myocardial infarction. There were no recent 
changes on comparison with earlier tracings. 
The patient was thought to have accelerated angina pectoris. Due to the 
electrocardiographic evidence of conduction system disease, he was given 
nifedipine (IO mg four times a day) in addition to nitroglycerin paste (1 inch 
every four hours). While visiting with his family the day following admission, 
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he made references to an airport that family members 
believed were out of context. Soon after their departure, he 
began insisting that he was in an airport and demanded his 
airplane tickets. He appeared agitated and was pacing 
restlessly. His vital signs were normal. When attempts were 
made to examine him, he accused the medical staff of 
trying to bring ruin on his family and causing him disgrace. 
He vehemently refused any further laboratory testing, 
claiming they were attempts by conspirators to do him 
harm. His family was contacted and returned immediately to 
remain with him overnight. The nifedipine was stopped. He 
persisted in accusations of conspiracy until he fell asleep 
that evening. The next morning, he was subdued but coop- 
erative. In consultation with the psychiatry department, it 
was thought that he would benefit most by early discharge. 
He was discharged that morning, receiving isorbide dini- 
trate (10 mg four times daily) and sublingual nitroglycerin. 
Follow-up daily by phone and in the clinic one week later 
revealed that he had returned fully to his prior emotional 
state with adequate control of his angina pectoris. 
COMMENTS 
We present the second case of nifedipine-associated 
acute psychosis. The acute behavioral abnormalities in 
this patient were believed to be an adverse reaction to 
nifedipine for several reasons. This patient had no history 
of a psychiatric or dementing illness that may have spon- 
taneously worsened. As he was a frequent world traveler, 
used to unfamiliar surroundings, it was unlikely that re- 
moval from his home environment was causative. Fur- 
thermore, his family was present when the abnormal 
behavior began. His confusion began during the daylight 
hours and therefore “sundowning” was unlikely. He had 
been using nitroglycerin on a long-term basis, and there- 
fore nifedipine was the only new medication. Finally, the 
‘behavioral abnormalities reversed rapidly following dis- 
continuation of the nifedipine. 
Although the cause of psychotic disorders remains 
unknown, evidence suggests disturbances in neurotrans- 
mitter synthesis and release, particularly catecholamines. 
Excess dopaminergic activity has been suggested as a 
cause of psychosis [6]. Support for this hypothesis is 
derived from the observation that drugs that increase brain 
dopamine such as levodopa can induce a psychosis, and 
neuroleptic agents block dopaminergic activity in a fash- 
ion correlated with their anti-psychotic potency [6]. 
Calcium fluxes have been shown to be involved in 
neurotransmitter synthesis and release in nervous system 
tissue [2]. For example, calcium increases the activity of 
tyrosine hydroxylase, the rate-limiting enzyme in cate- 
cholamine synthesis, in noradrenergic neurons, whereas 
calcium chelation increases the activity of the enzyme in 
dopaminergic neurons [7]. Nifedipine acts upon channels 
that permit calcium passage through lipid membranes and 
is believed to plug such channels, inhibiting the influx of 
calcium [8]. Nifedipine may alter neurotransmitter synthe- 
sis and release through inhibition of calcium fluxes. In the 
central nervous system, calcium antagonism resulting in 
increased tyrosine hydroxylase activity in dopaminergic 
neurons would result in increased central dopaminergic 
activity, possibly altering behavioral patterns. 
An alternative explanation is based on the observation 
that vincristine, a microtubule inhibitor, causes decreased 
levels of dopamine-@-hydroxylase in human plasma [9]. 
Calcium channel antagonists also have an effect on mi- 
crotubular function [5], and their inhibition of dopamine-@- 
hydroxylase would increase the dopamine content of both 
dopaminergic and noradrenergic neurons in the central 
nervous system, again altering behavioral patterns. 
This case presents an association between nifedipine 
and acute psychosis. Although use of the calcium channel 
antagonists has been relatively devoid of serious adverse 
effects [I], increasing clinical experience has resulted in 
the description of new clinical syndromes [5,10]. Clini- 
cians should consider nifedipine along with other causes 
when faced with patients with acute psychosis. 
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